ARVEE · NSE
Arvee Laboratories (India) Limited
₹236.07
+13.02% (+₹27.2)
Prev. close
₹208.87
Volume
2,29,982
Delivery %
20.8%
As of
22 Sept 2026
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About Arvee Laboratories (India) Limited
Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also provides drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4amino pyridine, and 2chloro5nitrobenzoic acid. In addition, the company exports its products. Arvee Laboratories (India) Ltd. was incorporated in 2012 and is based in Ahmedabad, India.
Details
Sector
Basic Materials
Industry
Specialty Chemicals
CEO
Mr. Shalin Sudhakarbhai Patel
Headquarters
Ahmedabad
Employees
57
Website
arveelabs.comExchange
View on NSE ↗Key stats
Market cap
₹260.15 Cr
P/E ratio (TTM)
64.1
EPS (TTM)
₹3.68
Beta (1Y · daily vs NIFTY 50)
1.07
Beta (5Y · monthly vs NIFTY 50)
1.63
Shares float
69.56 L
EPS · quarter ended Jun 2026
₹1.54
Financial Performance
01 · Financials
FY21 growth needs FY20 filings, which the data source doesn't provide.
02 · Earnings Per Share (EPS)
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based
05 · Capital Structure & Asset Utilization
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
07 · Debt Level & Coverage
08 · Profit & Loss
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹47.38 Cr | ₹40.33 Cr | ₹62.48 Cr | ₹30.35 Cr | ₹38.49 Cr | ₹31.51 Cr | |
| EBITDA | ₹6.62 Cr | ₹6.13 Cr | ₹8.63 Cr | ₹3.58 Cr | ₹4.27 Cr | ₹3.88 Cr |
| ₹2.68 Cr | ₹2.57 Cr | ₹4.12 Cr | ₹1.05 Cr | ₹2.15 Cr | ₹2.53 Cr | |
| Diluted EPS | ₹2.43 | ₹2.34 | ₹3.74 | ₹0.95 | ₹1.95 | ₹2.29 |
09 · Balance Sheet
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹41.05 Cr | ₹38.68 Cr | ₹38.69 Cr | ₹38.56 Cr | ₹37.58 Cr | ₹43.26 Cr | |
| — | — | ₹1.00 Cr | ₹1.00 Cr | ₹1.03 Cr | ₹1.11 Cr | |
| Stockholders' equity | ₹21.44 Cr | ₹23.94 Cr | ₹28.06 Cr | ₹29.11 Cr | ₹31.26 Cr | ₹33.79 Cr |
Current assets, Trade receivables, Cash & equivalents, Non-current assets, CWIP, Others, Total debt, Long-term debt, Current (short-term) debt have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹1.71 Cr | ₹68.00 L | ₹2.93 Cr | ₹3.66 Cr | ₹-21.00 L | ₹-12.00 L | |
| Investing cash flow | ₹-60.41 L | ₹5.93 L | ₹-1.26 Cr | ₹-2.16 Cr | ₹-1.39 Cr | ₹50.35 L |
| ₹4.52 Cr | ₹-6.05 Cr | ₹-2.52 Cr | ₹-24.99 L | ₹-21.35 L | ₹-15.54 L | |
| Capital expenditure | — | — | ₹-1.48 Cr | ₹-2.59 Cr | ₹-1.85 Cr | ₹-2.83 Cr |
| End cash position | ₹6.61 Cr | ₹4.63 Cr | ₹53.75 L | ₹1.85 Cr | ₹21.10 L | ₹43.95 L |
Capital expenditure has filed figures for only some of the years shown — the missing years are left blank rather than estimated.
Annual only — the data source has no quarterly cash-flow-statement coverage.
11 · Shareholding Pattern
NSE, quarterly
| Line item | Sep 21 | Dec 21–Jun 22(3Q) | Sep 22–Jun 26(16Q) |
|---|---|---|---|
| Promoter | 73.50% | 73.50% | 73.50% |
| Public | 26.50% | 26.49% | 26.50% |
| Employee trusts | 0.00% | 0.00% | 0.00% |
Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.
12 · Peer Comparison
Basic Materials
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| UltraTech Cement Limited | ₹3.24 L Cr | ₹11,100 | 38.0 | 4.23 | 10.7% | 0.31 | +16.6% | -11.3% |
| JSW Steel Limited | ₹3.10 L Cr | ₹1,267 | 12.5 | 3.09 | 22.3% | 1.19 | +9.3% | +13.4% |
| Hindustan Zinc Limited | ₹2.50 L Cr | ₹590.5 | 14.6 | 11.05 | 61.1% | 0.39 | +18.6% | +28.6% |
| Asian Paints Limited | ₹2.34 L Cr | ₹2,448.5 | 49.0 | 10.95 | 20.2% | 0.18 | +5.1% | -1.4% |
| Tata Steel Limited | ₹2.31 L Cr | ₹183.4 | 21.0 | 2.27 | 10.6% | 0.90 | +6.2% | +7.0% |
| Hindalco Industries Limited | ₹2.18 L Cr | ₹973 | 13.3 | 1.59 | 9.8% | 0.73 | +15.0% | +30.5% |
| Grasim Industries Limited | ₹2.15 L Cr | ₹3,128.2 | 37.8 | 2.08 | 4.8% | 2.20 | +18.2% | +9.6% |
| Solar Industries India Limited | ₹1.68 L Cr | ₹19,265 | 84.0 | 26.75 | 26.7% | 0.29 | +30.6% | +31.3% |
| Vedanta Aluminium Metal Limited | ₹1.63 L Cr | ₹413.05 | 42.4 | — | — | — | — | — |
| Pidilite Industries Limited | ₹1.60 L Cr | ₹1,572.7 | 60.6 | 14.79 | 22.6% | 0.04 | +11.1% | -48.2% |
| JINDAL STEEL LIMITED | ₹1.15 L Cr | ₹1,141 | 42.4 | 2.26 | 6.6% | 0.44 | +5.5% | +10.5% |
| Arvee Laboratories (India) Limited | ₹260.15 Cr | ₹236.07 | 64.1 | 7.70 | 7.5% | 0.03 | -18.2% | +33.3% |
Ranked by market cap within Basic Materials, same metrics as the Fundamentals screener. Click a column to sort.
Documents
Annual reports
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.
Arvee Laboratories Share Price Falls 9.35%: Full Analysis
Arvee Laboratories' share price fell 9.35% to Rs 177, closing lower by Rs 18.25. The micro-cap chemicals stock experienced sustained intraday weakness with its high fixed at the open and the last traded level near the low. The decline occurred without a specific company-related trigger, while the stock trades at elevated valuation multiples compared to its industry peers.
Arvee Laboratories (India) Share Price rises 11.69%:
Arvee Laboratories (India) shares rose 11.69% to trade at Rs 183.10, up from its previous close of Rs 163.93. This price movement occurred on modest turnover, with no specific company-specific catalyst identified. The company, a micro-cap in the Chemicals sector, has a market capitalization of Rs 180.65 crore.